The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

Trastuzumab is the first of the monoclonal antibodies to be used in the treatment of those patients who have HER2-positive metastatic breast cancer. It is most effective when combined with ...

The traditional method of generating antibodies by immunizing animals struggles to make antibodies related to these protein complexes. Scientists have now demonstrated that fusing protein ...

Cite this: Trastuzumab as the Lead Monoclonal Antibody in Advanced Breast Cancer: Choosing Which Patient and When - Medscape - Feb 01, 2008. Disclosure: The author has no relevant affiliations or ...

Automation and machine learning are transforming antibody discovery at LabGenius, with the EVA™ platform enabling rapid, high ...

Philippine romantic comedy My Love Will Make You Disappear, which stars A-listers Kim Chiu and Paulo Avelino, has raked in approximately $500,000 across 225 screens in North America over its ...

trastuzumab, and others. The adalimumab segment is the largest revenue contributor to the market. Based on indication, the global biosimilar monoclonal antibodies market is segmented into oncology ...

The new Mac Studio is basically identical in form to its M2 predecessor. But when comparing the M4 Max and M3 Ultra models, there are a couple noteworthy hardware differences to point out ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data and AI, presented NeuLogiq® ...